TD Cowen Maintains Elanco Animal Health(ELAN.US) With Buy Rating, Cuts Target Price to $12
Leerink Partners Downgrades Elanco Animal Health(ELAN.US) to Hold Rating, Cuts Target Price to $9.5
Analysts Have Conflicting Sentiments on These Healthcare Companies: Geron (GERN), Genmab (GMAB) and Elanco Animal Health (ELAN)
BofA Securities Maintains Elanco Animal Health(ELAN.US) With Buy Rating, Cuts Target Price to $13
BofA Securities Adjusts Elanco Animal Health Price Target to $13 From $16, Maintains Buy Rating
Morgan Stanley Maintains Elanco Animal Health(ELAN.US) With Hold Rating, Cuts Target Price to $10
Stifel Maintains Elanco Animal Health(ELAN.US) With Buy Rating, Cuts Target Price to $13
Elanco Animal Health Is Maintained at Buy by Stifel
Elanco Animal Health Analyst Ratings
Piper Sandler Maintains Elanco Animal Health(ELAN.US) With Hold Rating, Maintains Target Price $12
Piper Sandler Keeps Their Hold Rating on Elanco Animal Health (ELAN)
TD Cowen Maintains Elanco Animal Health(ELAN.US) With Buy Rating, Cuts Target Price to $15
Elanco Animal Health: Strong Buy Rating Driven by Pet Health Growth and Innovative Products
Analysts Offer Insights on Healthcare Companies: Elanco Animal Health (ELAN), Senseonics Holdings (SENS) and Voyager Therapeutics (VYGR)
Elanco Animal Health Is Maintained at Neutral by Piper Sandler
Elanco Animal Health Analyst Ratings
Piper Sandler Maintains Elanco Animal Health(ELAN.US) With Hold Rating, Cuts Target Price to $12
Jefferies Maintains Elanco Animal Health(ELAN.US) With Buy Rating, Maintains Target Price $18
Cautious Hold Rating on Elanco Animal Health Amid Uncertain Growth Prospects
Leerink Partners Maintains Elanco Animal Health(ELAN.US) With Hold Rating, Cuts Target Price to $12